Treatment of advanced HER2-positive breast cancer: 2018 and beyond

Cancer Treatment Reviews
Noam F PondéMartine Piccart

Abstract

In the 1980s the importance of HER2 signalling to the aberrant behaviour of a subset of breast cancer cells was recognized for the first time and, consequently, a hitherto unknown subtype of breast cancer - HER2-positive (HER2+) breast cancer was identified. The development of the anti-HER2 class of drugs, first with trastuzumab, followed closely by lapatinib, pertuzumab, and T-DM1, has improved outcomes dramatically. Nevertheless, metastatic HER2+ breast cancer remains an incurable disease and new therapeutic options are needed. Additionally, the rapid changes in treatment standards 5 years ago have left unanswered numerous questions, including the "real-life" benefit of pertuzumab and T-DM1, since both the CLEOPATRA and EMILIA trials were conducted in populations that no longer exist in practice and, moreover, on the role of endocrine therapy in HER2+ disease. Furthermore, despite significant research efforts, including translational efforts and new imaging techniques, no predictive biomarkers have been clinically validated and therefore a more refined approach to treatment tailoring remains beyond our reach. Finally, a better understanding of resistance to currently existing anti-HER2 agents and of the role played by the mic...Continue Reading

Citations

Apr 2, 2019·Current Treatment Options in Oncology·Noam PondéMartine Piccart
Oct 1, 2019·Journal of Cellular Physiology·Afshin DerakhshaniBehzad Baradaran
May 9, 2019·Journal of Molecular Cell Biology·Quan YangYang Wang
Nov 11, 2019·Breast Cancer Research and Treatment·Natasha TraceyValerie G Brunton
Sep 29, 2019·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiba ZalloumMalek Zihlif
Mar 7, 2020·JCO Clinical Cancer Informatics·Hayley M DingerdissenRaja Mazumder
Apr 8, 2020·Expert Opinion on Biological Therapy·Paolo TarantinoGiuseppe Curigliano
Apr 25, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paolo TarantinoGiuseppe Curigliano
May 29, 2020·Future Oncology·Marcelle GoldnerNoam Pondé
Aug 23, 2019·Breast Cancer Research and Treatment·Nicolò Matteo Luca BattistiIan Smith
May 22, 2019·International Journal of Cancer. Journal International Du Cancer·Guoyin LiLintao Jia
Nov 24, 2019·Cancers·Amaia Eleonora MaennlingAhmad Fawzi Hussain
Nov 15, 2018·The Journal of Pathology·Amy E McCart ReedSunil R Lakhani
Oct 21, 2018·Drugs·Hannah A Blair
Mar 8, 2019·International Journal of Molecular Sciences·Gabriel RinnerthalerRichard Greil
Nov 7, 2018·Expert Opinion on Pharmacotherapy·Gaia GiannoneFilippo Montemurro
Jan 5, 2019·The Annals of Pharmacotherapy·Rutugandha ParanjpeMeghana V Trivedi
Sep 29, 2019·Pharmacological Reviews·Peter J Houghton, Raushan T Kurmasheva
Mar 19, 2020·Molecular Medicine Reports·Li LiuXiangyang Xiong
Sep 10, 2020·International Journal of Molecular Sciences·Michela PiezzoMichelino De Laurentiis
Apr 3, 2019·Future Oncology·Daniel EigerEvandro de Azambuja
Jun 12, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Soo-Chin LeeDario Campana
Jan 4, 2021·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Takamichi YokoeToshimi Takano
Dec 2, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Paolo TarantinoGiuseppe Curigliano
Feb 6, 2021·The Journal of International Medical Research·Zheling ChenKe Chen
Feb 4, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Homa SeyedmirzaeiNima Rezaei
Feb 7, 2021·International Journal of Molecular Sciences·Qiyu LiZhangyong Hong
Jun 4, 2019·La Presse médicale·Fanny Le DuVéronique Dieras

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Advanced Imaging of Cellular Signaling

Cell signaling is a vital mechanism for communication within cells and outside with the environment. Several different signaling pathways have been found and advanced imaging techniques are being developed to visualize the molecules involved in these signaling pathways. Find the latest research in advanced imaging of cellular signaling here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

American Society of Clinical Oncology Educational Book
Dimitrios ZardavasMartine Piccart
Deutsche medizinische Wochenschrift
Katharina SeiffertVolkmar Müller
American Society of Clinical Oncology Educational Book
M Martin, Sara López-Tarruella
© 2022 Meta ULC. All rights reserved